11.07.2019 • NewsAshlandElaine BurridgeIneos

Ashland Amends Composites Deal to Ineos

Ashland Amends Composites Deal to Ineos
Ashland Amends Composites Deal to Ineos

Ashland Global Holdings has amended the agreement for the sale of its composites business and German butanediol (BDO) plant to Ineos Enterprises. The US specialty chemicals company has removed the maleic business from the sale; the price remains unchanged at $1.1 billion.

The maleic assets comprise one facility in West Virginia, which generates annual revenue of about $75 million. Ashland said it will retain full ownership and be solely responsible for operating the maleic business going forward. However, it added that it intends to sell the maleic assets once the deal with Ineos has closed, with all proceeds, less reasonable costs incurred by Ashland, going to Ineos Enterprises.

Ashland did not elaborate further on the amendment, nor did it give any indication as to whether any other third party was interested in buying the maleic plant.

The sale of the composites business and Marl BDO plant is expected to close in late summer, subject to regulatory approvals and usual closing conditions.

The original agreement with Ineos Enterprises was announced last November. Ineos Enterprises has not commented on the amendment.

Ashland is retaining its BDO plant in Lima, Ohio, USA.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.